BMY Related Options
-
Stocks with implied volatility movement; GRPN BMY
-
Amylin (AMLN) volatility low into Bristol-Myers paying $5.3B
-
Amylin (AMLN) volatility flat on wide share price movement
-
Goldman Sachs Recommends Buying Options Ahead of Healthcare Conference
-
Active equity option families in first 35-minutes of trading according to Track Data are: NFLX BMY BAC AAPL
-
Active equity option families in first 40-minutes of trading according to Track Data are: BMY BAC PFE
-
Bristol-Myers Squibb (BMY) volatility flat at 20 into positive clinical results
-
Stocks with implied volatility movement; AXP BMY
-
Bristol-Myers (BMY) April volatility up into metastatic melanoma data
-
Bristol-Myers (BMY) volatility flat at 20 into metastatic melanoma data
-
Goldman Sachs Recommends Buying Bristol-Myer (BMY) Calls Ahead of Data
-
Bristol-Myers Squibb (BMY) volatility flat at 22 into EPS
-
Zymogenetics (ZGEN) volatility flat; Bristol-Meyers Squibb (BMY) purchasing ZGEN for $735M
-
Bristol-Myers (BMY) volatility flattens, as shares rally
-
Active equity option families in first 30-minutes of trading according to Track Data are: C BAC BMY AAPL
-
Bristol-Myers (BMY) volatility elevated into positive ipilumumab in melanoma
-
Bristol-Myers (BMY) volatility increases as shares trend lower into ASCO
-
Three stocks with implied volatility above mean; BAX MSFT BMY ACL
-
Active equity option families in first 30-minutes of trading according to Track Data are: C AAPL BAC BMY
-
Active equity option families in first 30 minutes of trading according to Track Data are: C BMY BAC RIMM
-
Active equity option families in first 60 minutes of trading: C BMY AAPL BAC
-
Active equity option families in first 30 minutes of trading : BMY GLD AAPL BAC
-
Bristol-Myers (BMY) volatility decreases as shares rally
-
Bristol-Myers (BMY) volatility at Elevated 48
-
Bristol-Myers (BMY) volatility flat at 41 into EPS
-
Bristol-Myers (BMY) August volatility at 32 into Proposal to acquire IMCL for $60
-
Bristol-Myers (BMY) December volatility Elevated into analyst meeting
-
Bristol-Myers (BMY) option volume Heavy on Elevated volatility of 30
-
Bristol-Myers (BMY) implied volatility flat at 24
-
Equity option family volume leaders in first 30-minutes of Trading: HD BMY MS
-
Equity option family volume leaders in first 30-minutes of Trading: BMY YHOO AAPL
-
Most active equity option families in first 30-minutes of Trading: GOOG, AAPL, BMY
-
Most active equity option families in first 30-minutes of Trading: GOOG MSFT MEDX BMY
-
Bristol-Myer Squibb (BMY) Option Volume Heavy as Implied Volatility Increases
-
Most active equity option families in first 30-minutes of Trading: AAPL BMY INTC SNDK
-
Bristol-Myers Squibb (BMY) option implied volatility of 21 is below its average of 24
-
Most active equity option families in first 85-minutes of Trading: BMY VC GOOG F
-
Most active equity option families in first 30-minutes of Trading: BMY RMBS AAPL RIG
-
Most active equity option families in first 50-minutes of Trading: INTC QCOM SBUX BMY ORCL
-
Bristol-Myers Squibb (BMY) September option implied volatility Elevated into Judge's Injunction
-
Most active equity option families in first 30-minutes of Trading: BMY CSCO HD XOM
-
Most active equity option families in first 30-minutes of Trading: BMY AAPL SAP CSCO TEVA
-
Most active equity option families in first 30-minutes of Trading: AAPL HPQ QCOM BMY EBAY
-
Most active equity option families in first 30-minutes of Trading: PFE BMY PD AAPL
-
Bristol-Myers Squibb (BMY) August option implied volatility Elevated into EPS
-
Most active equity option families in first 30-minutes of Trading: GM MT GOOG EBAY MICC ELN BMY
-
Most active equity option families in first 30-minutes of Trading: PFE BSX BMY ZMH LEN AMAT PD
-
American Society of Clinical Oncology (ASCO) participants June stock option implied Volatility
-
Most active equity option families in first 30-minutes of Trading: MSFT NEM AAPL SNDK BMY HD
-
Bristol-Myers Squibb-BMY options active on Plavix settlement
Back to BMY Stock Lookup
